Livzon Pharmaceutical Group Inc
01513
Company Profile
Business description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. It is a pharmaceutical group covering pharmaceutical R&D, production and commercialization. The company's products include chemical drugs, biological drugs, and traditional Chinese medicine. It distributes its products within domestic markets and to overseas markets. The company operates in a single operating segment in the PRC, i.e. the manufacture of pharmaceuticals.
Contact
38 Chuangye North Road
Headquarters Building, Jinwan District
Guangdong Province
Zhuhai519090
CHNT: +86 7568135888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
8,878
Stocks News & Analysis
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.10 | 41.30 | -0.45% |
| CAC 40 | 8,284.48 | 48.50 | 0.59% |
| DAX 40 | 23,965.06 | 222.62 | 0.94% |
| Dow JONES (US) | 48,218.25 | 301.68 | 0.63% |
| FTSE 100 | 10,591.10 | 8.14 | 0.08% |
| HKSE | 25,872.32 | 211.47 | 0.82% |
| NASDAQ | 23,183.74 | 280.84 | 1.23% |
| Nikkei 225 | 57,877.39 | 1,374.62 | 2.43% |
| NZX 50 Index | 13,017.26 | 2.92 | -0.02% |
| S&P 500 | 6,886.24 | 69.35 | 1.02% |
| S&P/ASX 200 | 8,970.80 | 43.20 | -0.48% |
| SSE Composite Index | 4,026.63 | 38.07 | 0.95% |